Using the Cancer Genome Atlas (TCGA) dataset to analyze the mRNA expression levels, we found that GBP5 was significantly upregulated in all the four GBM subtypes when compared to the normal brain tissues, and the expression levels of GBP5 in the mesenchymal subtype were the highest (Fig. 1C). Here, GBP5 is linked to glioblastoma.